RETRACTED: Polycomb repressive complex 2 binds and stabilizes NANOG to suppress differentiation-related genes to promote self-renewal

Jul 14, 2023iScience

Polycomb repressive complex 2 supports stem cell renewal by stabilizing NANOG and blocking differentiation genes

AI simplified

Abstract

The interaction between PRC2 and NANOG may serve as a new drug target for hepatocellular carcinoma (HCC).

  • Alcohol and HCV activate NANOG through TLR4 signaling, which is important for the development of tumor-initiating stem-like cells.
  • NANOG, along with the PRC2 complex, inhibits genes involved in energy production to support the growth of these cancer cells.
  • NANOG protein stability is enhanced by its binding to EED, preventing its degradation.
  • Loss of the human ARID1A gene may lead to resistance against therapies targeting fatty acid oxidation and PRC2.
  • In mouse models of HCC, disrupting the PRC2-NANOG interaction or inhibiting fatty acid oxidation effectively halted tumor growth.

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free